Added to YB: 2025-05-21
Pitch date: 2025-05-19
BAYN.DE [neutral]
Bayer Aktiengesellschaft
+51.56%
current return
Author Info
Duck Pond Value Research is seeking tranquil ponds with a value philosophy. Margin of safety is not just a mantra. Follow us for investment theses, sector reports, or our economic perspectives. Sometimes ponds can be moats. Sign up for the newsletter.
Company Info
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments.
Market Cap
EUR 28.5B
Pitch Price
EUR 23.13
Price Target
60.00 (+71%)
Dividend
0.38%
EV/EBITDA
7.40
P/E
-144.19
EV/Sales
1.33
Sector
Pharmaceuticals
Category
turnaround
Bayer Aktiengesellschaft - $BAYN.DE
BAYN.DE (update): 2025 'most difficult turnaround year' per CEO, facing ag sector headwinds, Xarelto patent loss, legal issues. Progress: workforce -9%, org restructuring from 12 to 6 layers (target 3). RoundUp: 60% win rate; new strategy aligns with farmers vs courts. Q1 pharma beat expectations, ag flat at midpoint. Valuation €60, 40% upside from current levels.
Read full article (6 min)